Cytotoxic chemotherapy

Oncology & cancer treatment · Planning care in Germany and Czechia

Clinical name
Systemic cytotoxic chemotherapy
German
Zytostatische / zytotoxische Chemotherapie
Czech
Cytotoxická chemoterapie / systémová protinádorová léčba

Uses medicines that damage or inhibit dividing cells. The exact drug combination is chosen for the cancer type, stage and treatment goal. It may precede surgery, follow local treatment or control advanced disease. It differs from immunotherapy and targeted therapy.

Two clinicians discussing a document in a clinic
Illustrative stock photograph · RDNE Stock project / Pexels

Time, hospital stay & appointments

Times are planning guides, not national averages or guaranteed schedules. They reflect published provider examples and patient guidance. The treating team confirms the individual plan, time needed near the clinic and fitness to travel. Waiting lists are not included.

Procedure or course duration
Treatment is organized in cycles with recovery intervals. Masaryk describes breaks commonly lasting 2–3 weeks; weekly and other schedules also exist. A cycle can contain several administration days, so cycles and visits are not interchangeable.
Hospital stay
Day-unit treatment, oral treatment at home or an inpatient stay may be appropriate depending on the regimen and monitoring needs. Infusion duration alone does not describe the time required at the hospital.
Visits and repeat attendance
Initial oncology review, laboratory checks and clinical assessment before treatment, each scheduled administration, and response assessments. The provider must specify the regimen, number of cycles and days per cycle before a meaningful total visit count is possible.
Recovery and travel planning
Agree who manages side effects between cycles and how urgent oncology care is accessed. Travel must fit the blood-test and treatment schedule, including possible postponements.

Sources & finding a provider

Editorial source check: 29 October 2026. This is educational information, not an individual clinical assessment.

These country-specific sources document the service or its clinical use; their inclusion does not indicate a RAUQ partnership. Case acceptance, appointment availability and payment arrangements require separate provider confirmation.